Trial Profile
Steady-State Pharmacokinetics of Tedizolid in Plasma and Sputum of Patients With Cystic Fibrosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 May 2022
Price :
$35
*
At a glance
- Drugs Tedizolid (Primary) ; Tedizolid (Primary)
- Indications Cystic fibrosis
- Focus Pharmacokinetics
- 18 Jun 2018 Results (n=11) published in the Antimicrobial Agents and Chemotherapy.
- 08 May 2018 Status changed from recruiting to completed.
- 08 Oct 2017 Results (n=6) assessing pharmacokinetics of IV/PO tedizolid in plasma in patients presented at the IDWeek 2017.